A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers

Neuromuscul Disord. 2015 Dec;25(12):921-7. doi: 10.1016/j.nmd.2015.09.005. Epub 2015 Sep 8.


Congenital myasthenic syndromes (CMSs) are a group of rare genetic disorders of the neuromuscular junction resulting in structural or functional causes of fatigable weakness that usually begins early in life. Mutations in pre-synaptic, synaptic and post-synaptic proteins have been demonstrated in human cases, with more than half involving aberrations in nicotinic acetylcholine receptor (AChR) subunits. CMS was first recognized in dogs in 1974 as an autosomal recessive trait in Jack Russell Terriers (JRTs). A deficiency of junctional AChRs was demonstrated. Here we characterize a CMS in 2 contemporary cases of JRT littermates with classic clinical and electromyographic findings, and immunochemical confirmation of an approximately 90% reduction in AChR protein content. Loci encoding the 5 AChR subunits were evaluated using microsatellite markers, and CHRNB1 and CHRNE were identified as candidate genes. Sequences of the splice sites and exons of both genes revealed a single base insertion in exon 7 of CHRNE that predicts a frameshift mutation and a premature stop codon. We further demonstrated this pathogenic mutation in CHRNE in archival tissues from unrelated JRTs studied 34 years ago.

Keywords: Animal model; Canine; Muscle nicotinic acetylcholine receptor; Myasthenia gravis; Neuromuscular junction.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Dogs
  • Frameshift Mutation*
  • Intercostal Muscles / pathology
  • Male
  • Myasthenic Syndromes, Congenital / genetics*
  • Myasthenic Syndromes, Congenital / pathology
  • Myasthenic Syndromes, Congenital / physiopathology
  • Receptors, Nicotinic / genetics*


  • Receptors, Nicotinic